Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
The Oncologist|February 14, 2019
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive ChemoradiotherapyDevarati Mitra, Nora K Horick, Diane G Brackett, et al.
The Oncologist|August 23, 2020
Chemoradiation-Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal CanalGrace Lee, Daniel W Kim, Vinayak Muralidhar, et al.
Journal of the American College of Surgeons|February 2, 2023
Tolerability, Attrition Rates, and Survival Outcomes of Neoadjuvant FOLFIRINOX for Nonmetastatic Pancreatic Adenocarcinoma: Intent-to-Treat AnalysisZhi Ven Fong, Fidel Lopez Verdugo, Carlos Fernandez-Del Castillo, et al.
The New England Journal of Medicine|February 25, 2026
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C-Mutated TumorsEcaterina E Dumbrava, Geoffrey I Shapiro, Aparna R Parikh, et al.
The Oncologist|October 31, 2018
Enrichment of HER2 Amplification in Brain Metastases from Primary Gastrointestinal MalignanciesDevarati Mitra, Jeffrey W Clark, Helen A Shih, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 9, 2017
Prognostic Significance of Surgical Margin Size After Neoadjuvant FOLFOX and/or FOLFIRI for Colorectal Liver MetastasesCynthia L Miller, Martin S Taylor, Motaz Qadan, et al.
Journal of the National Cancer Institute|June 26, 2023
The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadershipRebecca A Snyder, Barbara Burtness, May Cho, et al.
Annals of Surgical Oncology|September 4, 2021
Neoadjuvant versus Postoperative Chemoradiotherapy is Associated with Improved Survival for Patients with Resectable Gastric and Gastroesophageal CancerDaniel W Kim, Grace Lee, Theodore S Hong, et al.
The Oncologist|May 2, 2019
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for TherapyAparna R Parikh, Yuting He, Ted S Hong, et al.
Cancer Medicine|May 18, 2018
Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysisSophia C Kamran, Jeffrey W Clark, Hui Zheng, et al.
Pageof 8